Daejeon, South Korea

Jee-Hee Seo


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jee-Hee Seo

Introduction

Jee-Hee Seo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of metabolic diseases. His work focuses on developing innovative solutions that can effectively address health issues related to lipid metabolism.

Latest Patents

Jee-Hee Seo holds a patent for an "Indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient." This invention relates to an indole derivative that effectively inhibits the activity of diacylglycerol acyltransferase (DGAT), which is known to induce metabolic diseases such as obesity, diabetes, hyperlipidemia, and fatty liver. By regulating lipid metabolism and energy metabolism, this invention has the potential to be a valuable asset in pharmaceutical compositions aimed at preventing or treating metabolic diseases. He has 1 patent to his name.

Career Highlights

Jee-Hee Seo is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research and development activities. His work has garnered attention for its innovative approach to tackling complex health issues.

Collaborations

He collaborates with notable colleagues, including Hyun Sun Lee and Mun-Ock Kim, who contribute to his research endeavors and help advance the field of biotechnology.

Conclusion

Jee-Hee Seo's innovative work in developing pharmaceutical solutions for metabolic diseases highlights his commitment to improving health outcomes. His contributions are paving the way for future advancements in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…